$SPCX

SpaceX stock hits new all-time low as AI capex jumps in Q2

SpaceX reported Q2 results as a public company, with revenue of $7.8B (vs $6.81B consensus) and adjusted EBITDA of $3.5B. Its AI segment had a $1.26B operating loss, while AI capex rose to $15.8B from $7.7B in Q1. Total capex was $18.37B. SpaceX shares fell 13.6% to a new all-time closing low, amid JPMorgan capex projections near $200B for 2027-28 and a Nvidia chip partnership for an AI payload.

Original reporting
Published Aug 7, 2026, 7:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 8:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX stock hits new all-time low as AI capex jumps in Q2 — source image
Decision brief

The 30-second read

$SPCXBearishMed
01

Why it matters

Near-term trading is likely dominated by (1) the magnitude of AI spending versus losses, and (2) expected incremental share supply from lockup expiration, both of which can overwhelm revenue/EBITDA beats.

02

Market read

The article combines a fresh earnings release with a concrete capex shock and a specific future float/supply catalyst, making it actionable for positioning around liquidity and valuation risk.

03

What to watch

The article cites JPMorgan’s view that ARR is rising and notes Starlink subscriber growth and EBITDA; those could offset capex concerns if investors focus on unit economics rather than near-term FCF pressure.

Relevance 8/10Novelty 7/10Timing: post-earnings, with lockup expiration and potential selling pressure looming

Background

This is SpaceX’s first reported quarter as a public company, with investors reacting to capex intensity and AI segment losses.

Company-level read

Ticker impact

$SPCXBearishMedium confidence
Context

SpaceX’s first public-company Q2 print showed AI capex jumping to $15.8B and shares fell 13.6% to a new all-time low.

Expected impact

Bearish bias for the next several sessions as investors weigh capex-to-return risk and potential selling pressure from lockup expiration.

Evidence & confidence

The article provides concrete Q2 financials (AI operating loss, AI spending, total capex), a same-day price move (down 13.6% to an all-time closing low), and a specific supply catalyst (lockup frees up to 20% of shares).

Market effects

Highlights the capital intensity of AI frontier infrastructure and may pressure sentiment toward other space and AI infrastructure plays with similar capex profiles.

Primarily US-listed growth/space sentiment; could spill into broader risk appetite for high-burn AI infrastructure names.

Nvidia chip supply exclusivity for SpaceX’s AI needs may reinforce demand expectations for datacenter GPU ecosystems, though the article does not quantify revenue impact.

Counterpoint

Despite the capex surge, revenue and adjusted EBITDA both beat consensus, and ARR could reach $100B, implying the spending may be funding a faster monetization curve than the market assumes.

Key entities

  • SpaceX

    Reported Q2 results as a public company, including AI segment operating loss and a sharp increase in AI capex, and announced an Nvidia partnership for an in-orbit AI payload.

  • Nvidia

    Partnered with SpaceX to design the Starmind AI-1 payload using Rubin GPUs and Vera CPUs, with Nvidia described as the exclusive chip supplier for SpaceX’s AI needs.

  • Tesla

    Mentioned as a potential merger target with SpaceX, which could create additional geopolitical and regulatory considerations if pursued.

Related articles

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.

$SPCXMed

SPCX Surges 16%: Lockup Expiration Passes Cleanly

SpaceX (NASDAQ: SPCX) rose 15.8% on Aug. 7, closing at $133.11 after its first post-IPO lockup expiration on Aug. 6 passed without a broad insider selloff. The move followed Q2 results on Aug. 4, when revenue rose 92% to $7.81B. Next unlocks are Aug. 20 and late September.

$SPCXMed

Top Analyst Drops Sharp Take on SpaceX Stock

Argus Research upgraded newly public SpaceX (NASDAQ:SPCX) to Buy from Hold and set a $160 price target. The firm cited Q2 results with revenue up 92% to $7.8B versus $6.93B consensus and a $541M loss, better than expected. Argus expects revenue near $110B in 2027, supporting a ~20x projected-sales valuation amid concerns over rising AI infrastructure spending and share unlocks.

$SPCXMed

SpaceX Stock Surges 10.5% as Argus Sees Rapid AI Payback

Space Exploration Technologies (NASDAQ:SPCX) rose over 12% in Friday trading after Argus upgraded the stock to Buy from Hold and set a $160 price target. Argus cited faster-than-expected AI spending payback. The company reported Q revenue up 92% to $7.81B, adjusted EBITDA up to $3.54B, and AI revenue up 247% to $2.56B, with AI segment profit. Net loss was $541M and AI capex was $15.83B.